KEGG: osa:9268322
UniGene: Os.100097
ABCG49 belongs to the ABC transporter family, specifically the G subfamily, in rice (Oryza sativa). ABC transporters are membrane proteins that utilize ATP to transport various substrates across cellular membranes. In plants, ABCG transporters are involved in processes including lipid transport, pathogen resistance, and adaptation to environmental stresses. The ABCG49 antibody enables researchers to study the expression, localization, and function of this transporter in various rice tissues and under different experimental conditions .
The ABCG49 antibody (CSB-PA168567XA01OFG) has been validated for Western blotting (WB) and enzyme-linked immunosorbent assay (ELISA) applications. These techniques allow researchers to detect and quantify ABCG49 protein in rice samples. The antibody has been specifically validated for identifying the antigen in these applications, ensuring reliable results when proper protocols are followed .
The ABCG49 antibody has been specifically developed for reactivity with Oryza sativa subsp. japonica (Rice). It is raised in rabbits against a recombinant immunogen representing the ABCG49 protein from rice. Researchers should note that cross-reactivity with other plant species has not been established in the provided data, and such information would require additional validation testing .
The ABCG49 antibody is supplied in a specific buffer composed of 0.03% Proclin 300 as a preservative, 50% glycerol, and 0.01M PBS at pH 7.4. This composition is critical for maintaining antibody stability and functionality. The glycerol prevents freezing damage, Proclin 300 inhibits microbial growth, and the PBS buffer maintains optimal pH for antibody stability. Researchers should be aware that altering this buffer composition could potentially affect antibody performance in experimental applications .
The ABCG49 antibody undergoes antigen affinity purification, which specifically isolates antibodies that bind to the target antigen. This purification method is crucial for research applications as it enhances specificity by removing non-specific antibodies from the preparation. For critical experiments, researchers should consider that different purification methods can impact antibody specificity and background signal in various applications. Antigen affinity purification typically provides higher specificity than protein A/G purification methods .
When designing Western blot experiments with ABCG49 antibody, multiple controls are essential:
| Control Type | Implementation | Purpose |
|---|---|---|
| Positive Control | Rice extract with known ABCG49 expression | Confirms antibody functionality |
| Negative Control | Non-expressing tissue or ABCG49-knockout samples | Establishes specificity |
| Loading Control | Probing for housekeeping protein (e.g., actin) | Ensures equal loading across lanes |
| Secondary Antibody Control | Primary antibody omitted | Detects non-specific secondary antibody binding |
| Blocking Peptide | Pre-incubation with immunizing peptide | Confirms signal specificity |
The inclusion of these controls helps distinguish genuine signals from artifacts and validates experimental findings. For polyclonal antibodies like the ABCG49 antibody, batch-to-batch variation may exist, making thorough validation particularly important .
Sample preparation is critical for successful detection of membrane proteins like ABCG49. For Western blotting, researchers should:
Extract total protein using a buffer containing appropriate detergents (e.g., 1-2% Triton X-100 or NP-40) to solubilize membrane proteins
Include protease inhibitors to prevent degradation
Avoid excessive heating (keep below 70°C) to prevent aggregation of membrane proteins
Optimize protein loading (typically 20-50 μg of total protein)
Consider native vs. reducing conditions depending on epitope accessibility
For immunohistochemistry, tissue fixation and antigen retrieval methods should be optimized specifically for ABCG49. Since membrane proteins can present challenges in preservation of structure and epitope accessibility, multiple fixation methods may need to be tested .
While specific optimal dilutions for ABCG49 antibody applications must be determined empirically by each lab, general starting ranges based on similar polyclonal antibodies are:
| Application | Starting Dilution Range | Optimization Approach |
|---|---|---|
| Western Blotting | 1:500 - 1:2000 | Titration series with constant protein amount |
| ELISA | 1:1000 - 1:5000 | Checkerboard titration |
Researchers should conduct preliminary experiments with a dilution series to determine the optimal concentration that maximizes specific signal while minimizing background. The optimal dilution may vary depending on sample type, protein expression level, and detection method .
A comprehensive validation approach for ABCG49 antibody should include multiple orthogonal methods:
Genetic approaches: Testing on ABCG49 knockout/knockdown samples versus wild-type
Orthogonal detection: Comparing results with multiple antibodies targeting different epitopes
Expression pattern analysis: Verifying tissue-specific expression matches known patterns
Molecular weight confirmation: Ensuring detected bands match predicted molecular weight
Signal depletion: Pre-incubation with immunizing peptide should eliminate specific signals
Recombinant protein controls: Testing against purified recombinant ABCG49 protein
This multi-method validation strategy significantly increases confidence in antibody specificity and reduces the risk of misleading experimental results .
Polyclonal antibodies like the ABCG49 antibody inherently exhibit batch-to-batch variation due to differences in animal immune responses. To address this challenge:
Maintain detailed records of antibody lot numbers used in each experiment
Validate each new lot against previous lots using standardized positive controls
Create a laboratory reference standard from a well-characterized lot
Consider purchasing larger quantities of a single, validated lot for long-term projects
Implement quantitative validation metrics (e.g., signal-to-noise ratio) to compare lots
These approaches help ensure experimental reproducibility despite the inherent variation in polyclonal antibody production .
While ABCG49 antibody is not explicitly validated for immunoprecipitation (IP), researchers can adapt it for this purpose through careful protocol optimization:
Crosslinking optimization: Determine optimal crosslinking conditions to preserve protein complexes
Detergent selection: Test multiple detergents (e.g., digitonin, DDM, CHAPS) at various concentrations to solubilize the membrane protein while preserving native interactions
Antibody coupling: Covalently couple the antibody to protein A/G beads to prevent antibody contamination in the eluate
Elution strategy: Develop gentle elution methods that preserve complex integrity
Complex verification: Use mass spectrometry to identify co-precipitated proteins
This approach can potentially reveal interaction partners of ABCG49, providing insights into its functional networks in rice cells .
The ABC transporter family contains multiple members with structural similarities, creating potential for cross-reactivity. Advanced researchers can implement several strategies to ensure signal specificity:
Epitope analysis: Perform in silico analysis of the immunizing peptide sequence against other rice ABC transporters to identify potential cross-reactive proteins
Competitive binding assays: Test inhibition with peptides from homologous regions of related transporters
Heterologous expression: Express individual ABC transporters in a non-plant system and test for antibody binding
Correlation analysis: Compare protein levels detected by antibody with mRNA expression data for ABCG49 and related transporters
Mass spectrometry validation: Confirm identity of immunoprecipitated or immunoblotted proteins
These approaches can help distinguish genuine ABCG49 signals from potential cross-reactivity with related proteins .
When encountering detection difficulties with ABCG49 antibody, a systematic troubleshooting approach is recommended:
| Issue | Potential Causes | Solutions |
|---|---|---|
| No signal | Insufficient protein expression | Confirm ABCG49 expression in sample; use positive control |
| Ineffective protein extraction | Optimize extraction buffer for membrane proteins | |
| Epitope destruction | Try multiple sample preparation methods; avoid excessive heating | |
| Insufficient antibody concentration | Increase antibody concentration; reduce washing stringency | |
| Weak signal | Suboptimal blocking | Test different blocking agents (BSA, milk, commercial blockers) |
| Detection system sensitivity | Use more sensitive detection method (e.g., ECL+ vs. standard ECL) | |
| Antibody degradation | Use fresh antibody aliquot; verify storage conditions | |
| Multiple bands | Cross-reactivity | Increase antibody dilution; optimize washing conditions |
| Protein degradation | Add protease inhibitors; reduce sample processing time | |
| Post-translational modifications | Characterize using additional techniques (e.g., mass spectrometry) |
This structured approach helps identify and address specific experimental issues affecting ABCG49 detection .
Plant samples often contain compounds that can interfere with antibody-based detection. Advanced approaches to distinguish specific from non-specific signals include:
Independent confirmation: Use orthogonal detection methods like mass spectrometry
Signal competition: Pre-incubate antibody with excess target peptide to block specific binding
Sample fractionation: Compare signal in membrane-enriched versus soluble fractions
Molecular weight verification: Confirm that detected bands match predicted ABCG49 size
Genetic manipulation: Compare signal in wild-type versus ABCG49-deficient plants
Signal quantitation: Establish dose-response relationships with varying sample concentrations
These strategies can significantly enhance confidence in signal specificity when working with complex plant materials .
Emerging technologies are transforming antibody validation approaches and could enhance ABCG49 antibody applications:
CRISPR/Cas9 knockout validation: Creating targeted ABCG49 knockouts in rice to provide definitive negative controls for antibody validation
Synthetic recombinant antibodies: Developing recombinant versions of successful ABCG49 antibodies for improved reproducibility
Proximity labeling techniques: Using ABCG49 antibody in conjunction with BioID or APEX2 systems to identify proximal proteins in the native cellular context
Single-cell proteomics: Applying ABCG49 antibody in emerging single-cell protein analysis platforms to study cell-to-cell variation
Deep learning validation: Using AI-based systems similar to AF2Complex to predict and validate antibody-antigen interactions
These advanced approaches could significantly enhance the reliability and utility of ABCG49 antibody in plant research.
Recent advances in antibody engineering could be applied to improve ABCG49 detection:
Epitope-focused engineering: Creating antibodies targeting unique, conserved epitopes of ABCG49
Bispecific antibodies: Designing antibodies that recognize two distinct ABCG49 epitopes simultaneously to enhance specificity
Affinity maturation: Improving binding affinity through directed evolution approaches
Fragment adaptation: Using smaller antibody fragments (Fab, scFv) for improved tissue penetration in microscopy applications
Computational design: Employing structure-based computational approaches to design higher-specificity antibody variants
These engineering approaches could potentially create next-generation ABCG49 antibodies with enhanced performance characteristics for challenging research applications .